![](/assets/images/picto-drapeau-france-3a76576a5d60a512053b4612ab58dae5.png)
5. Conclusion
To date, only hydroxyapatite powders have been used as mineral adjuvants in oncology vaccines. They are used in therapeutic vaccines on the market in veterinary medicine and have produced good clinical results, which it is beyond the scope of this article to discuss, with few side effects.
For therapeutic vaccination in oncology, the adjuvant is an essential element, particularly for vaccines with autologous antigens purified from tumors. These antigens have low antigenicity and are contaminated with normal proteins. The adjuvant must therefore be able to make the abnormal proteins "visible" to the immune system, and not provoke an immune response against those that are not. Calcium hydroxyapatite appears to be a good mineral adjuvant for this application
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
![](/assets/images/logo-eti-286623ed91fa802ce039246e516e5852.png)
The Ultimate Scientific and Technical Reference
This article is included in
Functional materials - Bio-based materials
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Conclusion
Bibliography
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
![](/assets/images/logo-eti-286623ed91fa802ce039246e516e5852.png)
The Ultimate Scientific and Technical Reference